The Democratic Republic of Congo has received 70,000 doses of the Ervebo vaccine to combat the worsening Bundibugyo Ebola outbreak. Of these, 20,000 doses are earmarked for a Phase III trial targeting the Bundibugyo virus, while 50,000 will be administered to frontline and health workers. The delivery aims to strengthen the country's response to the outbreak.
Don't miss out on breaking stories and in-depth articles.
